DSM and Lonza Reinforce Nutritionals Partnership
The extended partnership is also a promising commitment to the production sites of Visp and Lalden, showing that they are able to deliver high quality products at competitive costs.
22/06/09 DSM Nutritional Products Ltd and Lonza Ltd have announced the early renewal and extension of their long-time collaboration in the production facilities in Visp and Lalden, Wallis, Switzerland, without disclosing financial details. Lonza has for decades been a critical supplier for the services and raw materials for the Vitamins, Carotenoids, and aroma chemicals produced by DSM Nutritional Products. Within the framework of this new contract, the parties are reviewing the organisational setup for the 147 Lonza employees working at the Lalden site of DSM Nutritional Products.
In a joint statement the companies said that ‘in today’s environment it becomes of increasing importance to intensify partnerships in order to be able to innovate, deliver the highest quality, and secure future growth at competitive conditions. All these elements are intrinsically part of the partnership between Lonza and DSM Nutritional Products.’
"We are very pleased to continue our partnership with DSM. The common utilization of the infrastructure is benefiting both partners. The extended partnership is also a promising commitment to the production sites of Visp and Lalden, showing that they are able to deliver high quality products at competitive costs”, comments Lonza CEO Stefan Borgas.
"We have many interests in common here in Visp and Lalden and the collaboration between Lonza and DSM is very close. We are excited about the extension of the existing partnership by many years”, adds Leendert Staal, President and CEO of DSM Nutritional Products.
The collaboration between the companies dates back to 1965, when the predecessor company Teranol AG was founded to produce vitamin A and E. As Lonza commissioned at that same time its cracker, which could supply the necessary raw materials acetylene and hydrogen, the decision was made to locate the new Teranol production site in Lalden next to existing Lonza infrastructure.
Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. Its products and services span its customers’ needs from research to final product manufacture. Lonza is the global leader in the production and support of active pharmaceutical ingredients both chemically as well as biotechnologically. Biopharmaceuticals are one of the key growth drivers of the pharmaceutical and biotechnology industries. Lonza has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the development of novel medicines and healthcare products. Lonza is a leader in cell-based research, endotoxin detection and cell therapy manufacturing. Lonza is also a leading provider of value chemical and biotech ingredients to the nutrition, hygiene, preservation, agro and personal care markets. Lonza is headquartered in Basel, Switzerland and is listed on the SWX Swiss Exchange. In 2008, Lonza had sales of CHF 2.937 billion.
DSM Nutritional Products is the world's leading supplier of vitamins, carotenoids and other fine chemicals to the feed, food, pharmaceutical and personal care industries. The business has sales of over EUR 2 billion and a long tradition as a pioneer in the discovery of new products, new formulations and attractive applications for all industry segments.
